Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velphoro vs Phoslyra in Pediatric CKD Hyperphosphatemia
NCT02688764Phase 3Terminated
- Sponsor
- CSL Vifor
- Start
- May 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of iron sucrose in hyperphosphatemia, sponsored by CSL Vifor. Started May 2016; status: terminated.
02
Drugs
iron sucrose
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT02688764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02688764.